Study of treatments for long-term inflammatory diseases
Part of Bones, joints & muscles, Digestive system, Immune system & allergy, Infections, Skin clinical trials.
This study looks at how chronic inflammatory illnesses progress over time and how treatments affect symptoms and disease markers. You may be invited if you’re receiving care for certain bowel, joint, or skin inflammatory conditions at the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated at Besançon University Hospital for a long-term inflammatory bowel or joint or skin condition
- Your condition is one of these: Crohn’s disease, ulcerative colitis, or indeterminate colitis
- OR your condition is one of these inflammatory joint/arthritis diseases: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or other inflammatory spine/joint arthritis
- OR your condition is one of these inflammatory skin diseases: psoriasis or a specific painful skin condition called Verneuil’s disease
- You must meet the study’s standard diagnosis rules your clinician uses (clinical, imaging, and tissue sample if needed)
- You must agree to take part (no refusal) and you can’t be in an emergency situation or unable to consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study collects information and samples from people with active inflammatory bowel disease who need surgery or an endoscopy. It aims to better understand these conditions and improve future treatments.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This is a study that follows people with an immune-related illness at Lille University Hospital to better understand their care needs over time. By collecting information regularly, the study may help improve how future patients are monitored and treated.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.